Quizartinib for untreated FLT3-ITD-positive acute myeloid leukaemia: A Single Technology Appraisal

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherNational Institute for Health and Care Excellence
Publication statusPublished - 12 Jun 2024

Cite this